According to Biomerica latest financial reports the cash on hand of BMRA is $9.72M, an increase of 64.26% to 2022. At the end of 2022 company had $5.92M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $9.72M | 64.26% |
2022 | $5.92M | 40.90% |
2021 | $4.20M | -51.40% |
2020 | $8.64M | 1158.19% |
2019 | $686.78K | - |